0000950170-24-062570.txt : 20240520
0000950170-24-062570.hdr.sgml : 20240520
20240520180557
ACCESSION NUMBER: 0000950170-24-062570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240516
FILED AS OF DATE: 20240520
DATE AS OF CHANGE: 20240520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GROVES REGINA E
CENTRAL INDEX KEY: 0001653877
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 24966293
MAIL ADDRESS:
STREET 1: 5751 COPLEY DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
4
1
ownership.xml
4
X0508
4
2024-05-16
false
0001674930
Fulgent Genetics, Inc.
FLGT
0001653877
GROVES REGINA E
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE
EL MONTE
CA
91731
true
false
false
false
false
Common Stock
2024-05-16
4
A
false
4000
0
A
8000
D
Stock Option (Right to Buy)
22.50
2024-05-16
4
A
false
5481
0
A
2034-05-15
Common Stock
5481
5481
D
Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
/s/ Paul Kim as Attorney-in-Fact
2024-05-20